Skip to main content

Articles

Page 69 of 108

  1. In this review, we examine the evidence for mammographic density as an independent risk factor for breast cancer, describe the risk prediction models that have incorporated density, and discuss the current and...

    Authors: Celine M Vachon, Carla H van Gils, Thomas A Sellers, Karthik Ghosh, Sandhya Pruthi, Kathleen R Brandt and V Shane Pankratz
    Citation: Breast Cancer Research 2007 9:217
  2. Hypoxia-inducible factor (HIF)-1α levels in invasive breast carcinoma have been shown to be an adverse prognostic indicator. Cellular HIF-1α activity is regulated by factor-inhibiting hypoxia-inducible factor ...

    Authors: Ern Yu Tan, Leticia Campo, Cheng Han, Helen Turley, Francesco Pezzella, Kevin C Gatter, Adrian L Harris and Stephen B Fox
    Citation: Breast Cancer Research 2007 9:R89
  3. The central importance of tumour neovascularization has been emphasized by clinical trials using antiangiogenic therapy in breast cancer. This review gives a background to breast tumour neovascularization in in s...

    Authors: Stephen B Fox, Daniele G Generali and Adrian L Harris
    Citation: Breast Cancer Research 2007 9:216
  4. Characterizing and differentiating between malignant tumors, benign tumors, and normal breast tissue is increasingly important in the patient presenting with breast problems. Near-infrared diffuse optical imag...

    Authors: Ronald X Xu, Donn C Young, Jimmy J Mao and Stephen P Povoski
    Citation: Breast Cancer Research 2007 9:R88
  5. We performed gene expression analysis to identify molecular predictors of resistance to preoperative concomitant trastuzumab and paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide (T/FEC).

    Authors: Francisco J Esteva, Jing Wang, Feng Lin, Jaime A Mejia, Kai Yan, Kadri Altundag, Vicente Valero, Aman U Buzdar, Gabriel N Hortobagyi, W Fraser Symmans and Lajos Pusztai
    Citation: Breast Cancer Research 2007 9:R87
  6. Overexpression of the apoptosis-related protein clusterin is associated with breast cancer development and tumor progression. We describe the use of clusterin-specific antisense oligonucleotides and antibodies...

    Authors: Maximino Redondo, Teresa Téllez, Maria J Roldan, Alfonso Serrano, Maria García-Aranda, Martin E Gleave, Maria L Hortas and Miguel Morell
    Citation: Breast Cancer Research 2007 9:R86
  7. To understand which signalling pathways become deregulated in breast cancer, it is necessary to identify functionally significant gene expression patterns in the stem, progenitor, transit amplifying and differ...

    Authors: Matthew J Smalley, Marjan Iravani, Maria Leao, Anita Grigoriadis, Howard Kendrick, Tim Dexter, Kerry Fenwick, Joseph L Regan, Kara Britt, Sarah McDonald, Christopher J Lord, Alan MacKay and Alan Ashworth
    Citation: Breast Cancer Research 2007 9:R85
  8. The involvement of vitamin D receptor (VDR), which is a key mediator in the vitamin D pathway, in breast cancer etiology has long been of interest.

    Authors: Britton Trabert, Kathleen E Malone, Janet R Daling, David R Doody, Leslie Bernstein, Giske Ursin, Polly A Marchbanks, Brian L Strom, Mariela C Humphrey and Elaine A Ostrander
    Citation: Breast Cancer Research 2007 9:R84
  9. PALB2 has recently been identified as a breast cancer susceptibility gene. PALB2 mutations are rare causes of hereditary breast cancer but may be important in countries such as Finland where a founder mutation is...

    Authors: William D Foulkes, Parviz Ghadirian, Mohammed Reza Akbari, Nancy Hamel, Sylvie Giroux, Nelly Sabbaghian, Andrew Darnel, Robert Royer, Aletta Poll, Eve Fafard, André Robidoux, Ginette Martin, Tarek A Bismar, Marc Tischkowitz, Francois Rousseau and Steven A Narod
    Citation: Breast Cancer Research 2007 9:R83
  10. Many of the DNA sequence variants identified in the breast cancer susceptibility gene BRCA1 remain unclassified in terms of their potential pathogenicity. Both multifactorial likelihood analysis and functional ap...

    Authors: Paul K Lovelock, Amanda B Spurdle, Myth TS Mok, Daniel J Farrugia, Sunil R Lakhani, Sue Healey, Stephen Arnold, Daniel Buchanan, kConFab Investigators, Fergus J Couch, Beric R Henderson, David E Goldgar, Sean V Tavtigian, Georgia Chenevix-Trench and Melissa A Brown
    Citation: Breast Cancer Research 2007 9:R82
  11. Large numbers of translational breast cancer research topics have been completed or are underway, but they differ widely in their immediate and/or future importance to clinical management. We therefore conduct...

    Authors: Mitch Dowsett, Aron Goldhirsch, Daniel F Hayes, Hans-Joerg Senn, William Wood and Giuseppe Viale
    Citation: Breast Cancer Research 2007 9:R81
  12. Proteasome inhibition is an attractive approach to anticancer therapy and may have relevancy in breast cancer treatment. Natural products, such as dietary flavonoids, have been suggested as natural proteasome ...

    Authors: Di Chen, Kristin R Landis-Piwowar, Marina S Chen and Q Ping Dou
    Citation: Breast Cancer Research 2007 9:R80
  13. Recently, genome-wide association studies of breast cancer revealed single nucleotide polymorphisms (SNPs) in five genes with novel association to susceptibility. While there is little doubt that the novel sus...

    Authors: Silje H Nordgard, Fredrik E Johansen, Grethe IG Alnæs, Bjørn Naume, Anne-Lise Børresen-Dale and Vessela N Kristensen
    Citation: Breast Cancer Research 2007 9:113
  14. Advances in genomic technology have improved our understanding of the genetic events that parallel breast cancer development. Because almost all mammary carcinomas develop in the terminal duct lobular units of...

    Authors: Teresa L Mastracci, Fouad I Boulos, Irene L Andrulis and Wan L Lam
    Citation: Breast Cancer Research 2007 9:215
  15. Signal transducers and activators of transcription (STATs) are mediators of cytokine and growth factor signaling. In recent years, STAT5b has emerged as a key regulator of tumorigenesis. STAT5b phosphorylation...

    Authors: Amanda M Weaver and Corinne M Silva
    Citation: Breast Cancer Research 2007 9:R79
  16. Seven SNPs in five genomic loci were recently found to confer a mildly increased risk of breast cancer.

    Authors: Petra EA Huijts, Maaike PG Vreeswijk, Karin HG Kroeze-Jansema, Catharina E Jacobi, Caroline Seynaeve, Elly MM Krol-Warmerdam, Pauline M Wijers-Koster, Jannet C Blom, Karen A Pooley, Jan GM Klijn, Rob AEM Tollenaar, Peter Devilee and Christi J van Asperen
    Citation: Breast Cancer Research 2007 9:R78
  17. Estrogen and estrogen receptor (ER)-mediated signaling are crucial for the etiology and progression of human breast cancer. Attenuating ER activities by natural products is a promising strategy to decrease bre...

    Authors: Cheng Jiang, Junming Guo, Zhe Wang, Bingxiu Xiao, Hyo-Jung Lee, Eun-Ok Lee, Sung-Hoon Kim and Junxuan Lu
    Citation: Breast Cancer Research 2007 9:R77
  18. The molecular mechanisms involved in breast cancer metastasis still remain unclear to date. In our previous study, differential expression of peroxiredoxin 6 was found between the highly metastatic MDA-MB-435H...

    Authors: Xin-Zhong Chang, Da-Qiang Li, Yi-Feng Hou, Jiong Wu, Jin-Song Lu, Gen-Hong Di, Wei Jin, Zhou-Luo Ou, Zhen-Zhou Shen and Zhi-Ming Shao
    Citation: Breast Cancer Research 2007 9:R76

    The Correction to this article has been published in Breast Cancer Research 2018 20:63

  19. Breast tissue expression of the ERBB proto-oncogene family has been extensively studied. It was recently shown that expression of epidermal growth factor receptor (EGFR; c-erbB-1) and epidermal growth factor rece...

    Authors: Kristjan S Asgeirsson, Amit Agrawal, Claire Allen, Anthony Hitch, Ian O Ellis, Caroline Chapman, Kwok L Cheung and John FR Robertson
    Citation: Breast Cancer Research 2007 9:R75
  20. P-cadherin is frequently over-expressed in high-grade invasive breast carcinomas and has been reported to be an enhancer of migration and invasion of breast cancer cells, being correlated with tumour aggressiv...

    Authors: Joana Paredes, Ana Luísa Correia, Ana Sofia Ribeiro, André Albergaria, Fernanda Milanezi and Fernando C Schmitt
    Citation: Breast Cancer Research 2007 9:214
  21. A greater understanding of the biological mechanisms responsible for de novo and acquired endocrine resistance has led to the rational design of clinical trials exploring the benefit of combining hormonal therapi...

    Authors: Alexandra F Leary, Bhawna Sirohi and Stephen RD Johnston
    Citation: Breast Cancer Research 2007 9:112
  22. At the time when metastatic disease is identified, assessment of human epidermal growth factor receptor (HER)2 status might help to optimize treatment decisions if HER2 status was not determined at first diagn...

    Authors: Tanja Fehm, Sven Becker, Silke Duerr-Stoerzer, Karl Sotlar, Volkmar Mueller, Diethelm Wallwiener, Nancy Lane, Erich Solomayer and Jonathan Uhr
    Citation: Breast Cancer Research 2007 9:R74
  23. Recent cohort studies have suggested an increased risk of breast cancer with long duration of smoking, and with smoking initiation before first birth. Cigarette smoking may have both carcinogenic effects and a...

    Authors: Yngve Bremnes, Giske Ursin, Nils Bjurstam and Inger T Gram
    Citation: Breast Cancer Research 2007 9:R73
  24. The absence of mutation or promoter hypermethylation in the BRCA2 gene in the majority of breast cancer cases has indicated alternative ways of its involvement, deregulated expression being one possibility. We sh...

    Authors: Sailesh Gochhait, Syed Irfan Ahmad Bukhari, Narendra Bairwa, Shivani Vadhera, Katayoon Darvishi, Mohammad Raish, Pawan Gupta, Syed Akhtar Husain and Rameshwar NK Bamezai
    Citation: Breast Cancer Research 2007 9:R71
  25. Breast cancer at a young age is associated with an unfavorable prognosis. Very young patients with breast cancer therefore are advised to undergo adjuvant chemotherapy irrespective of tumor stage or grade. How...

    Authors: Jos A van der Hage, J Sven D Mieog, Marc J van de Vijver and Cornelis JH van de Velde
    Citation: Breast Cancer Research 2007 9:R70
  26. It has been demonstrated that leukemia inhibitory factor (LIF) induces epithelium apoptosis through Stat3 activation during mouse mammary gland involution. In contrast, it has been shown that this transcriptio...

    Authors: Ana Quaglino, Carolina Schere-Levy, Leonardo Romorini, Roberto P Meiss and Edith C Kordon
    Citation: Breast Cancer Research 2007 9:R69
  27. Before any new methodology can be introduced into the routine diagnostic setting it must be technically validated against the established standards. To this end, a ring study involving five international patho...

    Authors: Marc van de Vijver, Michael Bilous, Wedad Hanna, Manfred Hofmann, Petra Kristel, Frédérique Penault-Llorca and Josef Rüschoff
    Citation: Breast Cancer Research 2007 9:R68
  28. Stromal fibroblasts can contribute to tumor invasion through the release of matrix metalloproteinases (MMPs). Population studies have suggested that single nucleotide polymorphisms (SNPs) in MMP genes influenc...

    Authors: Deborah L Holliday, Simon Hughes, Jacqueline A Shaw, Rosemary A Walker and J Louise Jones
    Citation: Breast Cancer Research 2007 9:R67
  29. The aim of the study was to perform a comparative analysis of LOH (loss of heterozygosity) in primary tumors as well as peripheral blood and bone marrow (BM) of patients with breast cancer (BCa).

    Authors: Heidi Schwarzenbach, Volkmar Müller, Cord Beeger, Miriam Gottberg, Nicole Stahmann and Klaus Pantel
    Citation: Breast Cancer Research 2007 9:R66
  30. Breast cancer is a heterogeneous group of tumors, and can be subdivided on the basis of histopathological features, genetic alterations and gene-expression profiles. One well-defined subtype of breast cancer i...

    Authors: Bas Kreike, Marieke van Kouwenhove, Hugo Horlings, Britta Weigelt, Hans Peterse, Harry Bartelink and Marc J van de Vijver
    Citation: Breast Cancer Research 2007 9:R65
  31. Accurate determination of human epidermal growth factor receptor 2 (HER2) status is essential for optimal patient management with trastuzumab (Herceptin). However, standard guidelines do not specify a particul...

    Authors: Anne Cayre, Florence Mishellany, Nicole Lagarde and Frédérique Penault-Llorca
    Citation: Breast Cancer Research 2007 9:R64
  32. De-regulation of the wingless and integration site growth factor (WNT) signaling pathway via mutations in APC and Axin, proteins that target β-catenin for destruction, have been linked to various types of huma...

    Authors: Thomas Schlange, Yutaka Matsuda, Susanne Lienhard, Alexandre Huber and Nancy E Hynes
    Citation: Breast Cancer Research 2007 9:R63
  33. Historically, the incidence rate of breast cancer among non-Hispanic white women living in the San Francisco Bay area (SFBA) of California has been among the highest in the world. Substantial declines in breas...

    Authors: Theresa HM Keegan, Ellen T Chang, Esther M John, Pamela L Horn-Ross, Margaret R Wrensch, Sally L Glaser and Christina A Clarke
    Citation: Breast Cancer Research 2007 9:R62

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions